FDA Inspection
Eli Lilly Italia SPAEli Lilly Italia SPA – FDA Inspection, Nov 4, 2016
Record Details
This FDA Inspection record concerns Eli Lilly Italia SPA, with an inspection on November 4, 2016, issued by the Office of Inspections and Investigations, covering human drugs.
- Person
- Meisha R. Sampson (Issuing Officer)
View Company Profile
ID · 9c03d3c4-8438-4bec-afc2-ebb8b0161c96
Inspection Facts
- Inspection number
- 990194
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Eli Lilly Italia SPA
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 4, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 10, 2023 | Not classified | Office of Inspections and Investigations |
Other documents for Eli Lilly Italia SPA
- FDA Inspection 1258572 - 2023-04-04
- FDA Inspection 1199645 - 2023-02-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.